leadf
logo-loader
AIM:AGY

Allergy Therapeutics PLC

Receive alerts
Market:
AIM
Market Cap:
£95.98 m
Price
15.00 GBX
Change
-3.54%
52 weeks high
21.50
52 weeks low
7.00

In brief

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

Snapshot

  • Profitable allergy specialist developing new inoculations
  • Strong revenue growth in Europe
  • Long pipeline of new products under development

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Allergy Therapeutics gets big forecast upgrade from finncap after trading update

The broker now expects profits to around £5m higher than its previous forecasts at £2.9m.

on 24/6/20